Pfizer and Moderna apparently ruled out any prospect of sharing their mRNA technology-based vaccines with the vaccine firms in developing countries on grounds that they are far too complex and require more than 100 raw materials.
Tag: WTO DG’s
- Home
- WTO DG’s